
Trends in Healthcare Payments Sixteenth Annual Report
The latest report explores how AI promises to reshape the future of healthcare, while consumers are pushing a great reset with their retail-grade expectations.
 
Healthcare Payments at an Inflection Point
The healthcare industry stands at a critical juncture. AI and evolving consumer expectations are redefining healthcare payments to raise the bar for speed, transparency, choice and trust. As the industry feels the pressure to innovate, the legacy, paper-based workflows still remain and create friction for all stakeholders.
CONSUMER PRESSURE
Affordability is Reshaping Consumer Behavior
Affordability is increasingly influencing consumer expectations. This is making the payment experience—speed, transparency, and choice—more important to satisfaction and provider loyalty.
PROVIDER FINANCIAL OUTLOOK
Collections Are Harder—And Refunds Expose the Gaps
Providers are working to protect margins as patient balances rise, yet many collections workflows remain manual and paper-based. Patient refunds show the depth of that disconnect.
DRIVING PAYMENT INNOVATION
Modernize Payments at Scale
The path forward is a scalable payments infrastructure. Payers can accelerate this modernization by shifting claim payments to no-cost ERA/EFT.
Modernizing healthcare payments can reduce friction for consumers and staff while improving provider cash flow and administrative efficiency.
WEBINAR
Trends in Healthcare Payments:
Key Insights Shaping the Industry
What are the trends impacting providers, payers and consumers? Join our webinar our Tuesday, June 16 at 2:00 PM ET to hear our healthcare payments experts dive into the industry trends you need to know.
Register for the WebinarNote: all information above is via the Trends in Healthcare Payments Sixteenth Annual Report.
This material was prepared exclusively for the benefit and internal use of the JPMC client or prospect to whom it is directly addressed (including such entity’s subsidiaries, the “Company” or “you”, as the context may require) in order to assist the Company in evaluating a possible transaction(s) and does not carry any right of disclosure to any other party. In preparing these materials, we have relied upon and assumed, without independent verification, the accuracy and completeness of all information available from public sources or which was provided to us by or on behalf of the Company or which was otherwise reviewed by us. This material is for discussion purposes only and is incomplete without reference to the other briefings provided by JPMC. This information is confidential and proprietary to our firm and may only be used by you to evaluate the products and services described here. Neither this material nor any of its contents may be copied, published, disclosed or used for any other purpose without the prior written consent of JPMC.
J.P. Morgan, JPMorgan, JPMorgan Chase, Chase and InstaMed are marketing names for certain businesses of JPMorgan Chase & Co. and its subsidiaries worldwide (collectively, “JPMC”, “we” or “us”, as the context may require). Products or services may be marketed and/or provided by banking affiliates such as JPMorgan Chase Bank, N.A., securities or other non-banking affiliates or other JPMC entities. JPMC contact persons may be employees or officers of any of the foregoing entities and the terms “J.P. Morgan”, “JPMorgan”, “JPMorgan Chase” “Chase” and “InstaMed” if and as used herein include as applicable all such employees or officers and/or entities irrespective of marketing name(s) used. Nothing in this material is a solicitation by JPMC of any product or service which would be unlawful under applicable laws or regulations.
Investments or strategies discussed herein may not be suitable for all investors. Any opinions, analyses and estimates included here reflect prevailing conditions and views as of this date. These factors could change, and you should consider this information to be indicative, preliminary and for illustrative purposes only. Any market and/or economic commentary in no way constitutes research and should not be treated as such. Neither JPMC nor any of its directors, officers, employees or agents shall incur in any responsibility or liability whatsoever to the Company or any other party with respect to the contents of any matters referred in, or discussed as a result of, this material, including any decision made or action taken in reliance upon or for any inaccuracies or errors in, or omissions from, the information in this material. JPMC is not acting as your agent, fiduciary or advisor, including, without limitation, as a Municipal Advisor under the Securities and Exchange Act of 1934. This material is not intended to provide, and should not be relied on for, accounting, legal, tax, investment, regulatory, technology or other recommendations or advice. Please consult your own tax, legal, accounting, investment or similar advisors concerning such matters.
Not all products and services are available in all geographic areas or to all customers. Eligibility for particular products and services is subject to final determination by JPMC and or its affiliates/subsidiaries, including satisfaction of applicable legal, tax, risk, credit and other due diligence, JPMC’s “know your customer,” anti-money laundering, anti-terrorism and other policies and procedures. This material does not constitute a commitment by any JPMC entity to extend or arrange credit or to provide any other products or services and JPMC reserves the right to withdraw at any time. All services are subject to applicable laws and regulations, approvals and notifications, and service terms and policies. The Company should examine the specific restrictions and limitations under the laws of its own jurisdiction that may be applicable to the Company due to its nature or to the products and services referred herein.
Notwithstanding anything to the contrary, the statements in this material are not intended to be legally binding. Any products, services, terms or other matters described herein (other than in respect of confidentiality) are subject to the terms of separate legally binding documentation and/or are subject to change without notice. Any mentions of third-party trademarks, brand names, products and services are for referential purposes only and any mention thereof is not meant to imply any sponsorship, endorsement, or affiliation. Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future become, subject to ongoing international, national and other regulatory guidance, reform and proposals for reform.
For more information, please consult: https://www.jpmorgan.com/global/disclosures/interbank_offered_rates
JPMorgan Chase Bank, N.A. Member FDIC. Deposits held in non-U.S. branches are not FDIC insured.
JPMorgan Chase Bank, N.A., organized under the laws of U.S.A. with limited liability